Repression of the prolactin promoter: A functional consequence of the heterodimerization between Pit-1 and Pit-1 β

Journal of Molecular Endocrinology

Volumn 35, Issue 2, 2005, Pages 317-331

  Sporici, R A ^b   Hodskins, J S ^b   Locasto, D M ^b   Meszaros, L B ^b   Ferry, A L ^b   Weidner, A M ^b   Rinehart, C A ^a   Bailey, J C ^b   Mains, I M ^b   Diamond, S E ^b  

^a WESTERN KENTUCKY UNIVERSITY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; GLUTATHIONE TRANSFERASE; PROLACTIN; TRANSCRIPTION FACTOR PIT 1;

ADENOHYPOPHYSIS; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DIMERIZATION; EXPRESSION VECTOR; GENE EXPRESSION; GENE MUTATION; GENE REPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYDROPHOBICITY; IN VITRO STUDY; PRIORITY JOURNAL; PROLACTIN RELEASE; PROTEIN PROTEIN INTERACTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; CREB-BINDING PROTEIN; DIMERIZATION; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; PITUITARY GLAND; PROLACTIN; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN ISOFORMS; RATS; RECOMBINANT FUSION PROTEINS; TRANSCRIPTION FACTOR PIT-1;

EID: 27644566926     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.1.01678     Document Type: Article

References (92)

1. Blankenstein O, Muhlenberg R, Kim C, Wuller S, Pfaffle R & Heimann G 2001 A new c-terminal located mutation (v272 ter) in the Pit-1 gene manifesting with severe congenital hypothyroidism. Possible functionality of the Pit-1 c-terminus. Hormone Research 56 81-86.
2. Bodner M & Karin M 1987 A pituitary-specific trans-acting factor can stimulate transcription from the growth hormone promoter in extracts of nonexpressing cells. Cell 50 267-275.
3. Bradford AP, Conrad KE, Wasylyk C, Wasylyk B & Gutierrez-Hartmann A 1995 Functional interaction of c-ets-1 and ghf-1/Pit-1 mediates Ras activation of pituitary-specific gene expression: mapping of the essential c-ets-1 domain. Molecular and Cellular Biology 15 2849-2857.
4. Bradford A, Brodsky KS, Diamond S, Kuhn L, Liu Y & Gutierrez-Hartmann A 2000 The Pit-1 homeodomain and beta-domain interact with ets-1 and modulate synergistic activation of the rat prolactin promoter. Journal Biological Chemistry 275 3100-3106.
5. Bradford M 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72 248-254.
6. Brown M, Parks J, Adess M, Rich B, Rosenthal I, Voss T, Vanderheyden TC & Hurley DL 1998 Central hypothyroidism reveals compound heterozygous mutations in the Pit-1 gene. Hormone Research 49 98-102.
7. Camper SA, Yao YAS & Rottman FM 1985 Hormonal regulation of the bovine prolactin promoter in rat pituitary tumor cells. Journal of Biological Chemistry 260 12246-12251.
8. Chothia C 1976 The nature of the accessible and buried surfaces in proteins. Journal of Molecular Biology 105 1-12.
9. Cohen L, Wondisford F, Salvatoni A, Maghnie M, Brucker-Davis F, Weintraub B & Radovick S 1995 A "hot spot" in the Pit-1 gene responsible for combined pituitary hormone deficiency: clinical and molecular correlates. Journal of Clinical Endocrinology and Metabolism 80 679-684.
10. Cohen L, Wondisford F & Radovick S 1996 Role of Pit-1 in the gene expression of growth hormone, prolactin, and thyrotropin. Endocrinology and Metabolism Clinics of North America 25 523-540.
11. Cohen LE, Hashimoto Y, Zanger K, Wondisford F & Radovick S 1999 Creb-independent regulation by CBP is a novel mechanism of human growth hormone gene expression. Journal of Clinical Investigation 104 1123-1130.
12. Conrad KE & Gutierrez-Hartmann A 1992 The Ras and protein kinase A pathways are mutually antagonistic in regulating rat prolactin promoter activity. Oncogene 7 1279-1286.
13. Day RN, Walder JA & Maurer RA 1989 A protein kinase inhibitor gene reduces both basal and multihormone-stimulated prolactin gene transcription. Journal of Biological Chemistry 264 431-436.
14. De Guzman RN, Martinez-Yamout MA, Dyson H & Wright P 2004 Interaction of the TAZ1 domain of the CREB-binding protein with the activation domain of CITED2: regulation by competition between intrinsically unstructured ligands for non-identical binding sites. Journal of Biological Chemistry 279 3042-3049.
15. Deardorff J & Sachs A 1997 Differential effects of aromatic and charged residue substitutions in the RNA binding domains of the yeast poly(A)-binding protein. Journal of Molecular Biology 269 67-81.
16. Dial R, Sun Z & Freedman S 2003 Three conformational states of the p300 CH1 domain define its functional properties. Biochemistry 42 9937-9945.
17. Diamond S & Gutierrez-Hartmann A 1996 A 26-amino acid insertion domain defines a functional transcription switch motif in Pit-1 beta. Journal of Biological Chemistry 271 28925-28932.
18. Diamond SE & Gutierrez-Hartmann A 2000 The Pit-1 beta domain dictates active repression and alteration of histone acetylation of the proximal prolactin promoter. Journal of Biological Chemistry 275 30977-30986.
19. Diamond S & Kirkegaard K 1994 Clustered charged-to-alanine mutagenesis of poliovirus RNA-dependent RNA polymerase yields multiple temperature-sensitive mutants defective in RNA synthesis. Journal of Virology 68 863-876.
20. Diamond SE, Chiono M & Gutierrez-Hartmann A 1999 Reconstitution of the protein kinase A response of the rat prolactin promoter: differential effects of distinct Pit-1 isoforms and functional interaction with Oct-1. Molecular Endocrinology 13 228-238.
21. Duval D, Jean A & Gutierrez-Hartmann A 2003 Ras signaling and transcriptional synergy at a flexible ets-1/Pit-1 composite DNA element is defined by the assembly of selective activation domains. Journal of Biological Chemistry 278 39684-39696.
22. Elsholtz H, Albert V, Treacy M & Rosenfeld M 1990 A two-base change in a POU factor-binding site switches pituitary-specific to lymphoid-specific gene expression. Genes and Development 4 43-51.
23. Elsholtz HP, Lew AM, Albert PR & Sundmark VC 1991 Inhibitory control of prolactin and Pit-1 gene promoters by dopamine. Journal of Biological Chemistry 266 22919-22925.
24. Ferry A, Jonsen M, Locasto DM, Brodsky K, Gutierrez-Hartmann A & Diamond SE 2005 Pit-1 beta blocks transcription in a DNA context-dependent manner. Journal of Endocrinology 185 173-185.
25. Fofanova O, Takamura N, Kinoshita E, Yoshimoto M, Tsuji Y, Peterkova V, Evgrafov O, Dedov I, Goncharov N & Yamashita S 1998 Rarity of Pit1 involvement in children from russia with combined pituitary hormone deficiency. American Journal of Medical Genetics 77 360-365.
26. Freedman S, Sun Z, Kung A, France D, Wagner G & Eck M 2003 Structural basis for negative regulation of hypoxia-inducible factor-1 alpha by CITED2. Nature Structural Biology 10 504-512.
27. Gonzalez M & Carlberg C 2002 Cross-repression, a functional consequence of the physical interaction of non-liganded nuclear receptors and POU domain transcription factors. Journal Biological Chemistry 277 18501-18509.
28. Gutierrez-Hartmann A, Siddiqui S & Loukin S 1987 Selective transcription and DNase I protection of the rat prolactin gene by GH3 pituitary cell-free extracts. PNAS 84 5211-5215.
29. Hashimoto K, Zanger K, Hollenberg A, Cohen L, Radovick S & Wondisford F 2000 Camp response element-binding protein-binding protein mediates thyrotropin-releasing hormone signaling on thyrotropin subunit genes. Journal of Biological Chemistry 275 33365-33372.
30. Hendriks-Stegeman BI, Augustijn K, Bakker B, Holthuizen P, van der Vliet PC & Jansen M 2001 Combined pituitary hormone deficiency caused by compound heterozygosity for two novel mutations in the POU domain of the Pit1/POU1F1 gene. Journal of Clinical Endocrinology and Metabolism 86 1545-1550.
31. Hermann S, Berndt K & Wright A 2001 How transcriptional activators bind target proteins. Journal of Biological Chemistry 276 40127-40132.
32. Herr W, Sturm RA, Clerc RG, Corcoran LM, Baltimore D, Sharp PA, Ingraham HA, Rosenfeld MG, Finney M, Ruvkun G & Horvitz HR 1988 The POU domain: a large conserved region in the mammalian pit-1, oct-1, oct-2, and caenorhabditis elegans unc-86 gene products. Genes and Development 2 1513-1516.
33. Heyl D, Schmitter S, Bouzit H, Johnson T, Hepp A, Kurtz K & Mousigian C 1994 Substitution of aromatic and nonaromatic amino acids for the Phe3 residue in the delta-selective opioid peptide deltorphin I: effects on binding affinity and selectivity. International Journal of Peptides and Protein Research 44 420-426.
34. Ingraham HA, Chen RP, Mangalam HJ, Elsholtz HP, Flynn SE, Lin CR, Simmons DM, Swanson L & Rosenfeld MG 1988 A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype. Cell 55 519-529.
35. Ingraham HA, Flynn SE, Voss JW, Albert VR, Kapiloff MS, Wilson L & Rosenfeld MG 1990 The POU-specific domain of Pit-1 is essential for sequence-specific, high affinity DNA binding and DNA-dependent Pit-1-Pit-1 interactions. Cell 61 1021-1033.
36. Irie Y, Tatsumi K, Kusuda S, Kawawaki H, Boyages SC, Nose O, Ichiba Y, Katsumata N & Amino N 1995 Screening for PIT1 abnormality by PCR direct sequencing method. Thyroid 5 207-211.
37. Iverson R, Day K, D'emden M, Day R & Maurer R 1990 Clustered point mutation analysis of the rat prolactin promoter. Molecular Endocrinology 4 1564-1571.
38. Kapiloff MS, Farkash Y, Wegner M & Rosenfeld MG 1991 Variable effects of phosphorylation of Pit-1 dictated by the DNA response elements. Science 253 786-789.
39. Karplus P 1997 Hydrophobicity regained. Protein Science 6 1302-1307.
40. Katz D, Reginato M & Lazar M 1995 Functional regulation of thyroid hormone receptor variant TR alpha 2 by phosphorylation. Molecular and Cellular Biology 15 2341-2348.
41. Kawashima S & Kanehisa M 2000 AAindex: amino acid index database. Nucleic Acids Research 28 374.
42. Kawashima S, Ogata H & Kanehisa M 1999 AAindex: amino acid index database. Nucleic Acids Research 27 368-369.
43. Keech CA & Gutierrez-Hartmann A 1989 Analysis of rat prolactin promoter sequences that mediate pituitary-specific and 3′,5′-cyclic adenosine monophosphate-regulated gene expression in vivo. Molecular Endocrinology 3 832-839.
44. Keech C, Jackson S, Siddiqui S, Ocran K & Gutierrez-Hartmann A 1992 Cyclic adenosine 3′,5′-monophosphate activation of the rat prolactin promoter is restricted to the pituitary-specific cell type. Molecular Endocrinology 6 2059-2070.
45. Kievit P & Maurer R 2005 The pituitary-specific transcription factor, Pit-1, can direct changes in the chromatin structure of the prolactin promoter. Molecular Endocrinology 19 138-147.
46. Kishimoto M, Okimura Y, Yagita K, Iguchi G, Fumoto M, Iida K, Kaji H, Okamura H & Chihara K 2002 Novel function of the transactivation domain of a pituitary-specific transcription factor, Pit-1. Journal of Biological Chemistry 277 45141-45148.
47. Klapper M 1977 The independent distribution of amino acid near neighbor pairs into polypeptides. Biochemical and Biophysical Research Communications 78 1018-1024.
48. Konzak KE & Moore DD 1992 Functional isoforms of Pit-1 generated by alternative mRNA splicing. Molecular Endocrinology 6 241-247.
49. Lacerte A, Lee E, Reynaud R, Canaff L, De Guise C, Devost D, Ali S, Hendy G & Lebrun JJ 2004 Activin inhibits pituitary prolactin expression and cell growth through SMADs, Pit-1 and menin. Molecular Endocrinology 18 1558-1569.
50. Lai J & Herr W 1992 Ethidium bromide provides a simple tool for identifying genuine DNA-independent protein associations. PNAS 89 6958-6962.
51. Lew A & Elsholtz H 1995 A dopamine-responsive domain in the N-terminal sequence of Pit-1. Transcriptional inhibition in endocrine cell types. Journal of Biological Chemistry 270 7156-7160.
52. Li S, Crenshaw EB III, Rawson E, Simmons DM, Swanson LW & Rosenfeld M 1990 Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 347 528-533.
53. Mains P, Sulston I & Wood W 1990 Dominant maternal-effect mutations causing embryonic lethality in caenorhabditis elegans. Genetics 125 351-369.
54. Maurer RA 1981 Transcriptional regulation of the prolactin gene by ergocryptine and cyclic AMP. Nature 294 94-97.
55. Moffett P, Reece M & Pelletier J 1997 The murine Sim-2 gene product inhibits transcription by active repression and functional interference. Molecular and Cellular Biology 17 4933-4947.
56. Morris AE, Kloss B, Mcchesney R, Bancroft C & Chasin LA 1992 An alternatively spliced Pit-1 isoform altered in its ability to trans-activate. Nucleic Acids Research 20 1355-1361.
57. Mounkes LC & Fuller M 1999 Molecular characterization of mutant alleles of the DNA repair/basal transcription factor haywire/ERCC3 in Drosophila. Genetics 152 291-297.
58. Murray MB, Tadaki DK, Campion SR, Lamerdin JA, Serpersu EH, Bradrick TD & Niyogi SK 1998 Structure-function analysis of a conserved aromatic cluster in the N-terminal domain of human epidermal growth factor. Protein Engineering 11 1041-1050.
59. Nakagawa S, Tager H & Steiner D 2000 Mutational analysis of invariant valine B12 in insulin: implications for receptor binding. Biochemistry 39 15826-15835.
60. Necela B & Pollenz R 1999 Functional analysis of activation and repression domains of the rainbow trout aryl hydrocarbon receptor nuclear translocator (rtARNT) protein isoforms. Biochemical Pharmacology 57 1177-1190.
61. Ohta K, Nobukuni Y, Mitsubuchi H, Fujimoto S, Matsuo N, Inagaki H, Endo F & Matsuda I 1992 Mutations in the Pit-1 gene in children with combined pituitary hormone deficiency. Biochemical and Biophysical Research Communications 189 851-855.
62. Parks J, Brown M, Hurley D, Phelps C & Wajnrajch M 1999 Heritable disorders of pituitary development. Journal of Clinical Endocrinology and Metabolism 84 4362-4370.
63. Pellegrini-Bouiller I, Belicar P, Barlier A, Gunz G, Charvet JP, Jaquet P, Brue T, Vialettes B & Enjalbert A 1996 A new mutation of the gene encoding the transcription factor Pit-1 is responsible for combined pituitary hormone deficiency. Journal of Clinical Endocrinology and Metabolism 81 2790-2796.
64. Pernasetti F, Milner R, Al AAA, De ZF, Chavez V, Muller M & Martial J 1998 Pro239 Ser: a novel recessive mutation of the Pit-1 gene in seven middle eastern children with growth hormone, prolactin, and thyrotropin deficiency. Journal of Clinical Endocrinology and Metabolism 83 2079-2083.
65. Pfaffle R, Dimattia G, Parks J, Brown M, Wit J, Jansen M, Van DNH, Van DBJL, Rosenfeld M & Ingraham H 1992 Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia. Science 257 1118-1121.
66. Pfaffle R, Blankenstein O, Wuller S & Kentrup H 1999 Combined pituitary hormone deficiency: role of Pit-1 and prop-1. Acta Paediatrica Supplement 88 33-41.
67. Pickett CA & Gutierrez-Hartmann A 1997. Molecular and cellular ontogeny of distinct pituitary cell types. In Pituitary Disease: Diagnosis and Treatment, Chapter 2 pp 1-31. Ed. Wierman ME. Totowa, NY: Humana Press, Inc.
68. Radovick S, Nations M, Du Y, Berg L, Weintraub B & Wondisford F 1992 A mutation in the POU-homeodomain of Pit-1 responsible for combined pituitary hormone deficiency. Science 257 1115-1118.
69. Razeto A, Ramakrishnan V, Litterst C, Giller K, Griesinger C, Carlomagno T, Lakomek N, Heimburg T, Lodrini M, Pfitzner E & Becker S 2004 Structure of the NCoA-1/SRC-1 PAS-B domain bound to the LXXLL motif of the STAT6 transactivation domain. Journal of Molecular Biology 336 319-329.
70. Rose G, Geselowitz A, Lesser GJ, Lee R & Zehfus M 1985 Hydrophobicity of amino acid residues in globular proteins. Science 229 834-838.
71. Roulet E, Armentero M, Krey G, Corthesy B, Dreyer C, Mermod N & Wahli W 1995 Regulation of the DNA-binding and transcriptional activities of Xenopus Laevis NFI-X by a novel C-terminal domain. Molecular and Cellular Biology 15 5552-5562.
72. Sanchez-Pacheco A, Pena P, Palomino T, Guell A, Castrillo JL & Aranda A 1998 The transcription factor GHF-1, but not the splice variant GHF-2, cooperates with thyroid hormone and retinoic acid receptors to stimulate rat growth hormone gene expression. FEBS Letters 422 103-107.
73. Sanyal S & Van Tol HH 1997 Dopamine D4 receptor-mediated inhibition of cyclic adenosine 3′,5′-monophosphate production does not affect prolactin regulation. Endocrinology 138 1871-1878.
74. Scully KM, Jacobson EM, Jepsen K, Lunyak V, Viadiu H, Carriere C, Rose DW, Hooshmand F, Aggarwal AK & Rosenfeld MG 2000 Allosteric effects of Pit-1 DNA sites on long-term repression in cell type specification. Science 290 1127-1131.
75. Segil N, Roberts S & Heintz N 1991 Mitotic phosphorylation of the oct-1 homeodomain and regulation of oct-1 DNA binding activity. Science 254 1814-1816.
76. Tashjian AHJ, Yasumura Y, Levine L, Sato GH & Parker ML 1968 Establishment of clonal strains of rat pituitary tumor cells that secrete growth hormone. Endocrinology 82 342-352.
77. Tatsumi K, Miyai K, Notomi T, Kaibe K, Amino N, Mizuno Y & Kohno H 1992 Cretinism with combined hormone deficiency caused by a mutation in the pit1 gene. Nature Genetics 1 56-58.
78. Theill LE, Castrillo JL, Wu D & Karin M 1989 Dissection of functional domains of the pituitary-specific transcription factor GHF-1. Nature 342 945-948.
79. Theill LE, Hattori K, Domenico D, Castrillo JL & Karin M 1992 Differential splicing of the GHF1 primary transcript gives rise to two functionally distinct homeodomain proteins. European Molecular Biology Organization Journal 11 2261-2269.
80. Tolon RM, Castillo AI & Aranda A 1998 Activation of the prolactin gene by peroxisome proliferator-activated receptor-alpha appears to be DNA binding-independent. Journal of Biological Chemistry 273 26652-26661.
81. Townson S, Kang K, Lee A & Oesterreich S 2004 Structure-function analysis of the estrogen receptor alpha corepressor scaffold attachment factor-B1: identification of a potent transcriptional repression domain. Journal of Biological Chemistry 279 26074-26081.
82. Vallette-Kasic S, Pellegrini-Bouiller I, Sampieri F, Gunz G, Diaz A, Radovick S, Enjalbert A & Brue T 2001 Combined pituitary hormone deficiency due to the F135C human Pit-1 (pituitary-specific factor 1) gene mutation: functional and structural correlates. Molecular Endocrinology 15 411-420.
83. Voss JW, Wilson L & Rosenfeld MG 1991 POU-domain proteins Pit-1 and oct-1 interact to form a heteromeric complex and can cooperate to induce expression of the prolactin promoter. Genes and Development 5 1309-1320.
84. Voss JW, Wilson L, Rhodes SJ & Rosenfeld MG 1993 An alternative Pit-1 RNA splicing product reveals modular binding and nonmodular transcriptional activities of the POU-specific domain. Molecular Endocrinology 7 1551-1560.
85. Vu C, Robblee J, Werner K & Fairman R 2001 Effects of charged amino acids at b and c heptad positions on specificity and stability of four-chain coiled coils. Protein Science 10 631-637.
86. Wertman KF, Drubin DG & Botstein D 1992 Systematic mutational analysis of the yeast act1 gene. Genetics 132 337-350.
87. Xia Z, Anderson M, Diaz M & Zeleznik-Le NJ 2003 MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein. PNAS 100 8342-8347.
88. Xu L, Lavinsky RM, Dasen JS, Flynn SE, Mcinerney EM, Mullen TM, Heinzel T, Szeto D, Korzus E, Kurokawa R, Aggarwal AK, Rose DW, Glass CK & Rosenfeld MG 1998 Signal-specific co-activator domain requirements for Pit-1 activation. Nature 395 301-306.
89. Zanger K, Cohen LE, Hashimoto K, Radovick S & Wondisford FE 1999 A novel mechanism for cyclic adenosine 3′,5′-monophosphate regulation of gene expression by CREB-binding protein. Molecular Endocrinology 13 268-275.
90. Zanger K, Radovick S & Wondisford F 2001 CREB binding protein recruitment to the transcription complex requires growth factor-dependent phosphorylation of its GF box. Molecular Cell 7 551-558.
91. Zhang Z, Varanasi U & Trumbly R 2002 Functional dissection of the global repressor Tup 1 in yeast: dominant role of the C-terminal repression domain. Genetics 161 957-969.
92. Zor T, De Guzman RN, Dyson H & Wright P 2004 Solution structure of the KIX domain of CBP bound to the transactivation domain of c-Myb. Journal of Molecular Biology 337 521-534.